ORTEXORTEX News
Tracking CR? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CR
Earnings PreviewCR

CR Bounces but Remains Deep in the Red Heading into Q3

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 27 Oct 2026, 04:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Crane Company reports Q3 results today against a backdrop of sharp underperformance, a stock that has rebounded modestly but remains down roughly 8% for the month.

The options market is leaning defensive. The put/call ratio closed Monday at 1.08, above its 20-day average of 0.93 and running at this elevated level for the third consecutive week. That is not extreme relative to Crane's own history, the 52-week high on the ratio is 1.70, but the directional shift is clear: protective positioning has been building since mid-October as the stock sold off. Crane closed at $190.48 on Monday, recovering 4.2% on the day after Thursday's sharp drop, but the one-month loss of 7.9% still leaves the stock roughly $46 below the analyst consensus target of $236.60. Borrow conditions give no support to a bearish thesis: availability is extraordinarily loose, with shares available to lend running at nearly 90 times current short interest. Cost to borrow is 0.45%, flat on the week and off 11% over the past month.

Short interest itself carries little signal. At 2.2% of the free float, it has risen about 13% over the past month in share terms but remains low in absolute terms, and the ORTEX short score of 32.8 reflects no unusual conviction from the short side. The lending market confirms this: with borrow so cheap and availability so wide, there is no mechanical pressure on either side from the short book.

The analyst community has been uniformly constructive for months without a recent change. DA Davidson holds a Buy with a $245 target and Stifel carried a Buy at $242 after raising both its rating and target in late July. BMO Capital initiated at Outperform with a $253 target in July. The bullish case rests on aerospace volume growth, military demand, and a margin expansion story that has taken operating margins from around 12% in 2021 to 19% in 2025. Bears point to Boeing production execution risk, short-cycle softness in process flow, and commodity cost pressure in steel, aluminum and copper that could erode the margin gains if pricing does not keep pace.

The prior two quarterly prints both resulted in first-day declines of between 5% and 9%, with five-day losses that were more contained. Retail attention, as measured by Wikipedia page views, has jumped to its highest z-score reading in recent months at 2.3, suggesting broader awareness of the print is elevated. The Q3 result will test whether the margin expansion narrative holds in a quarter where aerospace demand has remained firm but process flow headwinds have drawn more scrutiny, and whether management's commentary on the Boeing ramp gives the Street enough confidence to close the gap between the current price and where analysts have been anchoring their targets.

Stocks in this article

See the live data behind this article on ORTEX.

Open CR on ORTEX →

How this article was generated

Generated
27 Oct 2026, 04:19
Data as of
27 Oct 2026, 04:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.